Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells

Diabetes

Volumn 56, Issue 4, 2007, Pages 960-967

  Caballero, Sergio ^a   Sengupta, Nilanjana ^a   Afzal, Aqeela ^a   Chang, Kyung Hee ^a   Li Calzi, Sergio ^a   Guberski, Dennis L ^b   Kern, Timothy S ^c   Grant, Maria B ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b Biomedical Research Models Inc   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL INJURY; CD34 SELECTION; CELL ADHESION; CELL MIGRATION; CHRONIC DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; IN VITRO STUDY; ISCHEMIA; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE STUDY; RAT; REPERFUSION INJURY; RETINA CAPILLARY; RETINA INJURY; RETINOPATHY; STEM CELL; STEM CELL TRANSPLANTATION; STREPTOZOCIN DIABETES;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD34; CELL TRANSPLANTATION; CHRONIC DISEASE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; ISCHEMIA; MALE; MICE; MICE, INBRED C57BL; RATS; RATS, INBRED STRAINS; RETINAL VESSELS;

EID: 34047144378     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-1254     Document Type: Article

References (50)

1. Fadini GP, Sartore S, Baesso I, Lenzi M, Agostini C, Tiengo A, Avogaro A: Endothelial progenitor cells and the diabetic paradox. Diabetes Care 29:714-716, 2006
2. Awad O, Dedkov E, Jiao C, Bloomer S, Tomanek RJ, Schatteman GC: Differential healing activities of CD34+ and CD14+ endothelial cell progenitors. Arterioscler Thromb Vasc Biol 26:758-764, 2006
3. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, Kearne M, Magner M, Isner JM: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85:221-228, 1999
4. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T: Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967, 1997
5. Grant MB, May WS, Caballero S, Brown GA, Guthrie SM, Mames RN, Byrne BJ, Vaught T, Spoerri PE, Peck AB, Scott EW: Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 8:607-612, 2002
6. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S: Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95:952-958, 2000
7. Shi Q, Rafii S, Wu M-D, Wijelath E, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage L, Malcom A, Storb R, Hammond W: Evidence for circulating bone marrow-derived endothelial cells. Blood 92:362-367, 1998
8. Butler JM, Guthrie SM, Koc M, Afzal A, Caballero S, Brooks HL, Mames RN, Segal MS, Grant MB, Scott EW: SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest 115:86-93, 2005
9. Segal MS, Shah R, Afzal A, Perrault CM, Chang K, Schuler A, Beem E, Shaw LC, Li Calzi S, Harrison JK, Tran-Son-Tay R, Grant MB: Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes 55:102-109, 2006
10. Caballero S, Sengupta N, Crafoord S, Lund R, Kruse FE, Young M, Grant MB: The many possible roles of stem cells in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 242:85-90, 2004
11. Sengupta N, Caballero S, W. SE, Mames RN, Guthrie SM, Grant MB: Hemangioblast activity of stem cells as promoted by injury and modulated by nitric oxide in a model of retinal neovascularization. In ARVO Annual Meeting. Fort Lauderdale, FL, Association for Research in Vision and Ophthalmology, 2003
12. Ellis EA, Sengupta N, Caballero S, Guthrie SM, Mames RN, Grant MB: Nitric oxide synthases modulate progenitor and resident endothelial cell behavior in galactosemia. Antioxid Redox Signal 7:1413-1422, 2005
13. Awad O, Jiao C, Ma N, Dunnwald M, Schatteman GC: Obese diabetic mouse environment differentially affects primitive and monocytic endothelial cell progenitors. Stem Cells 23:575-583, 2005
14. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, Verhaar MC, Braam B, Rabelink TJ, van Zonneveld AJ: Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53:195-199, 2004
15. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC: Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106:2781-2786, 2002
16. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amore PA: Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101-111, 1994
17. Zheng L, Gong B, Hatala DA, Kern TS: Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Invest Ophthalmol Vis Sci 48:361-367, 2007
18. Feit-Leichman RA, Kinouchi R, Takeda M, Fan Z, Mohr S, Kern TS, Chen DF: Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes. Invest Ophthalmol Vis Sci 46:4281-4287, 2005
19. Guberski DL, Butler L, Manzi SM, Stubbs M, Like AA: The BBZ/Wor rat: clinical characteristics of the diabetic syndrome. Diabetologia 36:912-919, 1993
20. Grant MB, Ellis EA, Guberski DL: Immunocytochemical localization of vascular endothelial growth factor (VEGF), Flt and Flk-1 in the retina of BBZ/Wor rats. In American Diabetes Association, 57th Proceedings Boston, MA, 1997
21. Ellis EA, Guberski DL, Somogyi-Mann M, Grant MB: Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med 28:91-101, 2000
22. Li Q, Lau A, Morris TJ, Guo L, Fordyce CB, Stanley EF: A syntaxin 1, Galpha(o), and N-type calcium channel complex at a presynaptic nerve terminal: analysis by quantitative immunocolocalization. J Neurosci 24:4070-4081, 2004
23. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, Bastidas N, Bunting S, Steinmetz HG, Gurtner GC: Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 164:1935-1947, 2004
24. Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA: Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. J Clin Invest 106:571-578, 2000
25. Schatteman GC, Ma N: Old bone marrow cells inhibit skin wound vascularization. Stem Cells 24:717-721, 2006
26. Sivan-Loukianova E, Awad OA, Stepanovic V, Bickenbach J, Schatteman GC: CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J Vasc Res 40:368-377, 2003
27. Stepanovic V, Awad O, Jiao C, Dunnwald M, Schatteman GC: Leprdb diabetic mouse bone marrow cells inhibit skin wound vascularization but promote wound healing. Circ Res 92:1247-1253, 2003
28. Jiang S, Walker L, Afentoulis M, Anderson DA, Jauron-Mills L, Corless CL, Fleming WH: Transplanted human bone marrow contributes to vascular endothelium. Proc Natl Acad Sci U S A 101:16891-16896, 2004
29. Schatteman GC: Adult bone marrow-derived hemangioblasts, endothelial cell progenitors, and EPCs. Curr Top Dev Biol 64:141-180, 2004
30. Tamarat R, Silvestre JS, Le Ricousse-Roussanne S, Barateau V, Lecomte-Raclet L, Clergue M, Duriez M, Tobelem G, Levy BI: Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am J Pathol 164:457-466, 2004
31. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89:E1-E7, 2001
32. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593-600, 2003
33. Lambiase PD, Edwards RJ, Anthopoulos P, Rahman S, Meng YG, Bucknall CA, Redwood SR, Pearson JD, Marber MS: Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support. Circulation 109:2986-2992, 2004
34. Gardiner TA, Anderson HR, Stitt AW: Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes. J Pathol 201:328-333, 2003
35. Grant MB, Afzal A, Spoerri P, Pan H, Shaw LC, Mames RN: The role of growth factors in the pathogenesis of diabetic retinopathy. Expert Opin Investig Drugs 13:1275-1293, 2004
36. Heissig B, Hattori K, Friedrich M, Rafii S, Werb Z: Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases. Curr Opin Hematol 10:136-141, 2003
37. Harraz M, Jiao C, Hanlon HD, Hartley RS, Schatteman GC: CD34- blood-derived human endothelial cell progenitors. Stem Cells 19:304-312, 2001
38. Rehman J, Li J, Orschell CM, March KL: Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107:1164-1169, 2003
39. Schmeisser A, Garlichs CD, Zhang H, Eskafi S, Graffy C, Ludwig J, Strasser RH, Daniel WG: Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc Res 49:671-680, 2001
40. Polverini PJ, Cotran PS, Gimbrone MA Jr, Unanue ER: Activated macrophages induce vascular proliferation. Nature 269:804-806, 1977
41. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK, Oh BH, Lee MM, Park YB: Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24:288-293, 2004
42. Kamihata H, Matsubara H, Nishiue T, Fujiyama S, Tsutsumi Y, Ozono R, Masaki H, Mori Y, Iba O, Tateishi E, Kosaki A, Shintani S, Murohara T, Imaizumi T, Iwasaka T: Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104:1046-1052, 2001
43. Wollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, Fichtner S, Korte T, Hornig B, Messinger D, Arseniev L, Hertenstein B, Ganser A, Drexler H: Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet 364:141-148, 2004
44. Anghelina M, Krishnan P, Moldovan L, Moldovan NI: Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles. Am J Pathol 168:529-541, 2006
45. Badorff C, Brandes RP, Popp R, Rupp S, Urbich C, Aicher A, Fleming I, Busse R, Zeiher AM, Dimmeler S: Transdifferentiation of blood-derived human adult endothelial progenitor cells into functionally active cardiomyocytes. Circulation 107:1024-1032, 2003
46. Fogelstrand L, Hulthe J, Hulten LM, Wiklund O, Fagerberg B: Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance. Diabetologia 47:1948-1952, 2004
47. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP: A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J 18:1450 -1452, 2004
48. Patino R, Ibarra J, Rodriguez A, Yague MR, Pintor E, Fernandez-Cruz A, Figueredo A: Circulating monocytes in patients with diabetes mellitus, arterial disease, and increased CD14 expression. Am J Cardiol 85:1288-1291, 2000
49. Cipolletta C, Ryan KE, Hanna EV, Trimble ER: Activation of peripheral blood CD14 monocytes occurs in diabetes. Diabetes 54:2779 -2786, 2005
50. Thum T, Bauersachs J: Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function: simply effects of optimized drug treatment (Letter)? Eur Heart J 26:1685, 2005